Elongation factor 3D structures: Difference between revisions
From Proteopedia
Jump to navigationJump to search
Michal Harel (talk | contribs) No edit summary |
Michal Harel (talk | contribs) No edit summary |
||
| Line 16: | Line 16: | ||
**[[1b23]] - TaEF + Cys-tRNA<BR /> | **[[1b23]] - TaEF + Cys-tRNA<BR /> | ||
**[[3wxm]] – ApEF + plethora protein – ''Aeropyrum pernix''<br /> | **[[3wxm]] – ApEF + plethora protein – ''Aeropyrum pernix''<br /> | ||
**[[6ji2]] - ApEF + plethora protein + AP2<br /> | |||
**[[4h9g]], [[4lbv]], [[4lbw]], [[4lby]], [[4lbz]], [[4lc0]] – TtEF – ''Thermus thermophilus''<br /> | **[[4h9g]], [[4lbv]], [[4lbw]], [[4lby]], [[4lbz]], [[4lc0]] – TtEF – ''Thermus thermophilus''<br /> | ||
**[[4j0q]] – PpEF – ''Pseudomonas putida''<br /> | **[[4j0q]] – PpEF – ''Pseudomonas putida''<br /> | ||
**[[5w75]] – EF – ''Thermotoga neapolitana''<br /> | **[[5w75]] – EF – ''Thermotoga neapolitana''<br /> | ||
**[[5tbf]] – EF domain 2-3– ''Vibrio cholerae''<br /> | **[[5tbf]] – EF domain 2-3– ''Vibrio cholerae''<br /> | ||
**[[6htw]], [[6i8r]] – EF – synthetic<br /> | |||
*''EF-Tu complex with antibiotics'' | *''EF-Tu complex with antibiotics'' | ||
| Line 146: | Line 148: | ||
**[[1yby]] – EF – ''Clostridium thermocellum''<br /> | **[[1yby]] – EF – ''Clostridium thermocellum''<br /> | ||
**[[5j3b]] – AbEF <br /> | **[[5j3b]] – AbEF <br /> | ||
**[[6rji]] – SaEF <br /> | |||
**[[6rk3]] – SaEF - NMR<br /> | |||
**[[6s8z]] – EF – ''Corynebacterium glutamicum'' <br /> | |||
**[[5wxk]] – EF + EARP – ''Neisseria meningitidis''<br /> | **[[5wxk]] – EF + EARP – ''Neisseria meningitidis''<br /> | ||
| Line 166: | Line 171: | ||
**[[5bmu]] – hEF ε-1 + Glu tRNA ligase <br /> | **[[5bmu]] – hEF ε-1 + Glu tRNA ligase <br /> | ||
**[[5y6l]] – hEF ε-1 (mutant) + MetRS + AspRS + Glu/Pro tRNA ligase + P38<br /> | **[[5y6l]] – hEF ε-1 (mutant) + MetRS + AspRS + Glu/Pro tRNA ligase + P38<br /> | ||
**[[4c0s]] – rEF α-2 – rabbit<br /> | **[[4c0s]], [[6ra9]] – rEF α-2 – rabbit<br /> | ||
**[[5o8w]] – yEF α+β <br /> | **[[5o8w]] – yEF α+β <br /> | ||
**[[1nhy]] – yEF γ N terminal<br /> | **[[1nhy]] – yEF γ N terminal<br /> | ||
| Line 183: | Line 188: | ||
**[[5h7l]] - PhEF + L12<BR /> | **[[5h7l]] - PhEF + L12<BR /> | ||
**[[5h7k]] - PhEF + GDP<BR /> | **[[5h7k]] - PhEF + GDP<BR /> | ||
**[[6u45]] – MnEF + GMPPCP – ''Methanoperedens nitroreducens'' <BR /> | |||
**[[6u43]], [[6u44]] – MnEF (mutant) + GMPPCP <BR /> | |||
*EF-3 | *EF-3 | ||
| Line 213: | Line 220: | ||
**[[3h7h]] – hEF-Spt4 residues 2-117 + hEF-Spt5 residues 176-273<br /> | **[[3h7h]] – hEF-Spt4 residues 2-117 + hEF-Spt5 residues 176-273<br /> | ||
**[[6gmh]], [[6gml]] – hEF-Spt4 + EF-Spt5 + EF-Spt6 in transcription complex – Cryo EM<br /> | |||
**[[5oik]] – bEF-Spt4 + EF-Spt5 + RNA polymerase II <br /> | **[[5oik]] – bEF-Spt4 + EF-Spt5 + RNA polymerase II <br /> | ||
**[[2exu]] – yEF-Spt4 residues 1-99 + EF-Spt5 residues 285-375<br /> | **[[2exu]] – yEF-Spt4 residues 1-99 + EF-Spt5 residues 285-375<br /> | ||
**[[4zn3]], [[4zn1]] – EF-Spt4 + EF-Spt5 – ''Methanocaldococcus jannaschii'' <br /> | **[[4zn3]], [[4zn1]] – EF-Spt4 + EF-Spt5 – ''Methanocaldococcus jannaschii'' <br /> | ||
**[[5xon]], [[5xog]] – EF-Spt4 + EF-Spt5 + EF-Tfiis | **[[5xon]], [[5xog]], [[6ir9]], [[6j4w]], [[6j4x]], [[6j4y]], [[6j4z]], [[6j50]], [[6j51]] – EF-Spt4 + EF-Spt5 + EF-Tfiis in RNA polymerase II elongation complex - ''Komagataella phaffii'' - Cryo EM<br /> | ||
*EF-Spt5 | *EF-Spt5 | ||
| Line 236: | Line 244: | ||
**[[4z2n]] – hEF middle domain residues 644-930<br /> | **[[4z2n]] – hEF middle domain residues 644-930<br /> | ||
**[[4z2m]] – hEF middle domain + histone H3.1 + histone H4<br /> | **[[4z2m]] – hEF middle domain + histone H3.1 + histone H4<br /> | ||
**[[6gme]] – hEF SH2 domain residues 1317-1334<br /> | |||
**[[3psf]], [[3psi]] – yEF core domain residues 235-1259<BR /> | **[[3psf]], [[3psi]] – yEF core domain residues 235-1259<BR /> | ||
**[[3psj]], [[3psk]] – yEF SH2 domain residues 1247-1451<BR /> | **[[3psj]], [[3psk]] – yEF SH2 domain residues 1247-1451<BR /> | ||
| Line 276: | Line 285: | ||
**[[1lqb]], [[1lm8]] – hEloBC + von-Hippel Lindau disease tumor suppressor + hypoxia inducible factor 1 α<br /> | **[[1lqb]], [[1lm8]] – hEloBC + von-Hippel Lindau disease tumor suppressor + hypoxia inducible factor 1 α<br /> | ||
**[[6i7q]], [[6i7r]] – hEloBC + von-Hippel Lindau disease tumor suppressor + hypoxia inducible factor 2 α<br /> | |||
**[[3zrc]], [[3ztc]], [[3ztd]], [[3zun]], [[6fmi]], [[6fmj]], [[6fmk]], [[5nw2]], [[5nw1]], [[5nw0]], [[5nvz]], [[5nvy]], [[5nvx]], [[5nvw]], [[5nvv]], [[4w9l]], [[4w9k]], [[4w9j]], [[4w9i]], [[4w9h]], [[4w9g]], [[4w9f]], [[4w9e]], [[4w9d]], [[4w9c]], [[6gfy]] - hEloBC + von-Hippel Lindau disease tumor suppressor + inhibitor<br /> | **[[3zrc]], [[3ztc]], [[3ztd]], [[3zun]], [[6fmi]], [[6fmj]], [[6fmk]], [[5nw2]], [[5nw1]], [[5nw0]], [[5nvz]], [[5nvy]], [[5nvx]], [[5nvw]], [[5nvv]], [[4w9l]], [[4w9k]], [[4w9j]], [[4w9i]], [[4w9h]], [[4w9g]], [[4w9f]], [[4w9e]], [[4w9d]], [[4w9c]], [[6gfy]] - hEloBC + von-Hippel Lindau disease tumor suppressor + inhibitor<br /> | ||
**[[5t35]] - hEloBC + von-Hippel Lindau disease tumor suppressor + BRD4<br /> | **[[5t35]], [[6sis]] - hEloBC + von-Hippel Lindau disease tumor suppressor + BRD4<br /> | ||
**[[4wqo]] - hEloBC + von-Hippel Lindau disease tumor suppressor + cullin-2 <br /> | **[[4wqo]] - hEloBC + von-Hippel Lindau disease tumor suppressor + cullin-2 <br /> | ||
**[[6hr2]], [[6hay]], [[6hax]] - hEloBC + von-Hippel Lindau disease tumor suppressor + transcription activator <br /> | **[[6hr2]], [[6hay]], [[6hax]] - hEloBC + von-Hippel Lindau disease tumor suppressor + transcription activator <br /> | ||
| Line 287: | Line 297: | ||
**[[6i5n]], [[6i5j]] – hEloBC + suppressor of cytokine signaling + growth hormone receptor peptide<br /> | **[[6i5n]], [[6i5j]] – hEloBC + suppressor of cytokine signaling + growth hormone receptor peptide<br /> | ||
**[[6i4x]] – hEloBC + suppressor of cytokine signaling + erythropoietin peptide<br /> | **[[6i4x]] – hEloBC + suppressor of cytokine signaling + erythropoietin peptide<br /> | ||
**[[ | **[[6p59]] - hEloBC + virion infectivity factor + CBF b<br /> | ||
**[[3zkj]] - hEloBC + ankyrin rep<br /> | **[[3zkj]] - hEloBC + ankyrin rep<br /> | ||
**[[1vcb]] – hEloBC + VHL<br /> | **[[1vcb]] – hEloBC + VHL<br /> | ||
**[[6v9h]] – hEloBC + creatine kinase + ASB-9 – Cryo EM<br /> | |||
**[[2fnj]] - mEloBC + GUSTAVUS | **[[2fnj]] - mEloBC + GUSTAVUS | ||
}} | }} | ||
[[Category:Topic Page]] | [[Category:Topic Page]] | ||
Revision as of 10:27, 20 July 2020
3D structures of elongation factor
Updated on 20-July-2020
- 4hfx – hEloA F-box domain
- 4hfx – hEloA F-box domain
- Elongin C
- Elongin BC complex
- 1lqb, 1lm8 – hEloBC + von-Hippel Lindau disease tumor suppressor + hypoxia inducible factor 1 α
- 6i7q, 6i7r – hEloBC + von-Hippel Lindau disease tumor suppressor + hypoxia inducible factor 2 α
- 3zrc, 3ztc, 3ztd, 3zun, 6fmi, 6fmj, 6fmk, 5nw2, 5nw1, 5nw0, 5nvz, 5nvy, 5nvx, 5nvw, 5nvv, 4w9l, 4w9k, 4w9j, 4w9i, 4w9h, 4w9g, 4w9f, 4w9e, 4w9d, 4w9c, 6gfy - hEloBC + von-Hippel Lindau disease tumor suppressor + inhibitor
- 5t35, 6sis - hEloBC + von-Hippel Lindau disease tumor suppressor + BRD4
- 4wqo - hEloBC + von-Hippel Lindau disease tumor suppressor + cullin-2
- 6hr2, 6hay, 6hax - hEloBC + von-Hippel Lindau disease tumor suppressor + transcription activator
- 6gmr, 6gfx, 6bvb - hEloBC + von-Hippel Lindau disease tumor suppressor + hypoxia inducible factor peptide
- 5n4w - hEloBC + von-Hippel Lindau disease tumor suppressor + cullin-2 + RBX1
- 3zrf, 5lli, 6gmx, 6gmq, 6gmn, 6gfz - hEloBC + von-Hippel Lindau disease tumor suppressor
- 2c9w, 2izv, 2jz3, 5bo4 – hEloBC + suppressor of cytokine signaling
- 6c5x – hEloBC + suppressor of cytokine signaling + Gp130 peptide
- 6i5n, 6i5j – hEloBC + suppressor of cytokine signaling + growth hormone receptor peptide
- 6i4x – hEloBC + suppressor of cytokine signaling + erythropoietin peptide
- 6p59 - hEloBC + virion infectivity factor + CBF b
- 3zkj - hEloBC + ankyrin rep
- 1vcb – hEloBC + VHL
- 6v9h – hEloBC + creatine kinase + ASB-9 – Cryo EM
- 2fnj - mEloBC + GUSTAVUS
- 1lqb, 1lm8 – hEloBC + von-Hippel Lindau disease tumor suppressor + hypoxia inducible factor 1 α